Stress and psychological trauma as predictors of cancer-related fatigue in breast cancer patients (SaFE study)—study protocol of a prospective follow-up study

TL;DR

This study explores how stress and psychological trauma affect cancer-related fatigue in breast cancer patients over time.

Contribution

The study introduces and validates a global stress index (GSI) to measure stress in relation to cancer-related fatigue.

Findings

The GSI will be validated as a tool to assess stress load in oncological patients.

High stress levels measured by the GSI are hypothesized to correlate with increased cancer-related fatigue.

The study will track stress and fatigue in breast cancer patients before and after treatment.

Abstract

Cancer-related fatigue (CRF) is a common symptom of cancer and/or its treatment. Most cancer patients are affected during treatment, as well as years thereafter. Around a third of survivors report suffering from CRF. Those affected are often restricted in their everyday life. Acute and chronic stress are factors that increase a person’s vulnerability to develop CRF. In previous studies different instruments measuring acute and chronic stress related to CRF were used. However, a global instrument to determine individual stress load is lacking.

Therefore, a developed global stress index (GSI) combining specific measuring instruments for acute and chronic stress is validated on an oncological sample and its influence on fatigue is examined. It is hypothesized that individuals with a high global stress load measured by the GSI report higher levels of CRF. The data will be collected using questionnaires in participants suffering from breast cancer with a curative treatment approach. Participants will be surveyed during tumor-specific therapy and six months later. They receive a consultation if fatigue symptoms are strongly pronounced. The study is registered at Deutsches Register Klinischer Studien, no. DRKS DRKS00027864.

This will be the first study using the GSI as a valid measure for surveying longitudinally acute and chronic stress load in an oncological sample in relation to CRF symptom development. The GSI may help to identify tumor patients with high levels of stress in good time and thus prevent chronic fatigue.

Figures